Literature DB >> 24882379

Identifying sickle cell disease cases using administrative claims.

Sarah Reeves1, Erika Garcia2, Mary Kleyn3, Michelle Housey3, Robin Stottlemyer3, Sarah Lyon-Callo3, Kevin John Dombkowski4.   

Abstract

OBJECTIVE: To develop and test the accuracy of administrative claims method for identifying children with sickle cell disease (SCD) to enable quality of care assessments among children enrolled in Medicaid.
METHODS: All administrative claims with an SCD diagnosis were obtained from Michigan Medicaid from 2008 to 2011 for children ≤18 years, representing 1828 individuals. All Medicaid claims were obtained for these children and classified into categories on the basis of SCD care; these classifications were used to develop 37 alternative case definitions for identifying children with SCD. Children with ≥1 SCD claim in 2010 or 2011 were identified as confirmed SCD or not SCD using the gold standard of Michigan newborn screening administrative records. Measures of performance were calculated for each case definition for eligible children in 2010. Further validation of the case definitions was performed among eligible children in 2011.
RESULTS: In 2010, a total of 938 children met eligibility criteria and were linked to newborn screening records; 605 (59%) were confirmed SCD, and 333 (32%) were not SCD. Measures of performance varied among the 37 case definitions, and the 4 best case definitions on the basis of the sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve were validated among 924 children meeting eligibility criteria in 2011. The case definition of at least 3 SCD claims in any position identified children with SCD with the most accuracy, with an area under the ROC curve of 0.91 (95% confidence interval 0.89, 0.93).
CONCLUSIONS: This definition can be used to facilitate a more accurate identification of children with SCD in future studies. Further investigation is necessary to determine whether this method translates to other populations besides Michigan Medicaid-insured children.
Copyright © 2014 Academic Pediatric Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Medicaid; administrative claims; case identification; children; newborn screening; sickle cell disease

Mesh:

Year:  2014        PMID: 24882379      PMCID: PMC7197254          DOI: 10.1016/j.acap.2014.02.008

Source DB:  PubMed          Journal:  Acad Pediatr        ISSN: 1876-2859            Impact factor:   3.107


  32 in total

1.  Combining state administrative databases and provider records to assess the quality of care for children enrolled in Medicaid.

Authors:  J J Cotter; W R Smith; L F Rossiter; C B Pugh; J D Bramble
Journal:  Am J Med Qual       Date:  1999 Mar-Apr       Impact factor: 1.852

2.  Sickle cell disease-related pediatric medical expenditures in the U.S.

Authors:  Djesika D Amendah; Mercy Mvundura; Patricia L Kavanagh; Philippa G Sprinz; Scott D Grosse
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

3.  Emergency department visits made by patients with sickle cell disease: a descriptive study, 1999-2007.

Authors:  Hussain R Yusuf; Hani K Atrash; Scott D Grosse; Christopher S Parker; Althea M Grant
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

Review 4.  Pulmonary complications of sickle cell disease.

Authors:  Mark T Gladwin; Elliott Vichinsky
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

5.  Distribution of hemoglobinopathy variants by ethnicity in a multiethnic state.

Authors:  F W Lorey; J Arnopp; G C Cunningham
Journal:  Genet Epidemiol       Date:  1996       Impact factor: 2.135

6.  The Children's Health Insurance Program Reauthorization Act quality measures initiatives: moving forward to improve measurement, care, and child and adolescent outcomes.

Authors:  Denise Dougherty; Jeffrey Schiff; Rita Mangione-Smith
Journal:  Acad Pediatr       Date:  2011 May-Jun       Impact factor: 3.107

7.  Underuse of controller medications among Medicaid-insured children with asthma.

Authors:  Jonathan A Finkelstein; Paula Lozano; Harold J Farber; Irina Miroshnik; Tracy A Lieu
Journal:  Arch Pediatr Adolesc Med       Date:  2002-06

8.  Accuracy of administrative data for identifying patients with pneumonia.

Authors:  Dominik Aronsky; Peter J Haug; Charles Lagor; Nathan C Dean
Journal:  Am J Med Qual       Date:  2005 Nov-Dec       Impact factor: 1.852

9.  Pediatric asthma surveillance using Medicaid claims.

Authors:  Kevin J Dombkowski; Elizabeth A Wasilevich; Sarah K Lyon-Callo
Journal:  Public Health Rep       Date:  2005 Sep-Oct       Impact factor: 2.792

10.  Healthcare utilization and expenditures for low income children with sickle cell disease.

Authors:  Jean L Raphael; Craig L Dietrich; Deborah Whitmire; Donald H Mahoney; Brigitta U Mueller; Angelo P Giardino
Journal:  Pediatr Blood Cancer       Date:  2009-02       Impact factor: 3.167

View more
  36 in total

1.  Identification of patients with hemoglobin SS/Sβ0 thalassemia disease and pain crises within electronic health records.

Authors:  Ashima Singh; Javier Mora; Julie A Panepinto
Journal:  Blood Adv       Date:  2018-06-12

2.  Health outcomes and services in children with sickle cell trait, sickle cell anemia, and normal hemoglobin.

Authors:  Sarah L Reeves; Hannah K Jary; Jennifer P Gondhi; Mary Kleyn; Kevin J Dombkowski
Journal:  Blood Adv       Date:  2019-05-28

3.  Contribution of Sickle Cell Disease to the Pediatric Stroke Burden Among Hospital Discharges of African-Americans-United States, 1997-2012.

Authors:  Charlotte Baker; Althea M Grant; Mary G George; Scott D Grosse; Thomas V Adamkiewicz
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

4.  Antibiotic Prophylaxis for Children With Sickle Cell Anemia.

Authors:  Sarah L Reeves; Alison C Tribble; Brian Madden; Gary L Freed; Kevin J Dombkowski
Journal:  Pediatrics       Date:  2018-02-05       Impact factor: 7.124

5.  Association between clinical outcomes and metformin use in adults with sickle cell disease and diabetes mellitus.

Authors:  Sherif M Badawy; Amanda B Payne
Journal:  Blood Adv       Date:  2019-11-12

6.  Emergency department utilization by Californians with sickle cell disease, 2005-2014.

Authors:  Susan T Paulukonis; Lisa B Feuchtbaum; Thomas D Coates; Lynne D Neumayr; Marsha J Treadwell; Elliott P Vichinsky; Mary M Hulihan
Journal:  Pediatr Blood Cancer       Date:  2016-12-21       Impact factor: 3.167

7.  Performance of ICD-10-CM diagnosis codes for identifying children with Sickle Cell Anemia.

Authors:  Sarah L Reeves; Brian Madden; Meng Wu; Lauren S Miller; David Anders; Michele Caggana; Lindsay W Cogan; Mary Kleyn; Isabel Hurden; Gary L Freed; Kevin J Dombkowski
Journal:  Health Serv Res       Date:  2020-01-09       Impact factor: 3.402

8.  Health Care Utilization and Comorbidity History of North Carolina Medicaid Beneficiaries in a Controlled Substance "Lock-in" Program.

Authors:  Rebecca B Naumann; Stephen W Marshall; Jennifer L Lund; Asheley C Skinner; Christopher Ringwalt; Nisha C Gottfredson
Journal:  N C Med J       Date:  2019 May-Jun

9.  Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.

Authors:  Susan T Paulukonis; James R Eckman; Angela B Snyder; Ward Hagar; Lisa B Feuchtbaum; Mei Zhou; Althea M Grant; Mary M Hulihan
Journal:  Public Health Rep       Date:  2016 Mar-Apr       Impact factor: 2.792

10.  Transcranial Doppler Screening Among Children and Adolescents With Sickle Cell Anemia.

Authors:  Sarah L Reeves; Brian Madden; Gary L Freed; Kevin J Dombkowski
Journal:  JAMA Pediatr       Date:  2016-06-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.